Andrew Bell


DPhil Organic Chemistry, University of Oxford
BA Chemistry, University of Oxford

“I support leaders and teams across the whole pharmaceutical sector on their most important business issues. I work collaboratively with internal and external stakeholders to understand their motivations and use a structured and systematic approach in developing strategy. With the Novasecta team I am part of a strong group of consultants who work with a range of pharmaceutical and biotech clients.”
Andrew is a Partner at Novasecta and joined the team through the acquisition of Strategy in Life Sciences (SiLS), where he was the Founder and Managing Director. Andrew has gained consulting experience from working with a wide range of pharmaceutical and biotech companies on their critical strategy issues, which includes commercial and corporate strategy development, business plan development, merger and acquisition advice and portfolio development. Prior to establishing SiLS, Andrew was an Executive Director at AVOS Consulting where he helped to establish a European healthcare consulting practice. His previous consulting experience also includes positions at Charles River Associates, IMS Consulting and L.E.K. Consulting.


Novasecta has a different approach – you feel a sensitivity of working with a smaller consulting company which tailored its approach to help us start implementing the change